Medicine
Volume 37, Issue 4 , Pages 186-189, April 2009

Myelodysplastic disorders

Sally B Killick MD FRCP FRCPath is Consultant Haematologist at the Royal Bournemouth Hospital NHS Foundation Trust, Bournemouth, UK. Competing interests: Dr Killick has sat on advisory boards for Celgene Novartis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1357-3039(08)00360-5

doi:10.1016/j.mpmed.2008.12.003

Medicine
Volume 37, Issue 4 , Pages 186-189, April 2009

Article Tools

* Image Usage & Resolution